drugset / Trial / NCT00206986

Will Decreased Noradrenergic Activity Normalize Information Processing in Patients With Schizophrenia?

NCT00206986

RandomizedCrossoverTriple-blindTreatment

Summary

The investigators want to try to improve information processing in schizophrenic patients via pharmacological intervention. The hypothesis is that decreased noradrenergic activity will normalize information processing (PPI, P50 gating, P300, and mismatch negativity) in patients with schizophrenia.

Timeline

Start
2005-05
Primary completion
2011-12
Completion
2011-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Clonidine Other / unclassified 25 ug
Subject Clonidine Other / unclassified 50 ug
Subject Clonidine Other / unclassified 75 ug
Subject Clonidine Other / unclassified 150 ug

Indications